Advanced Search

 

Study ID Status Title Patient Level Data
114112 Completed A Randomized, Double-blind, Single Dose Crossover Study to Assess the Effect of Gabapentin Enacarbil on Cardiac Conduction as Compared with Placebo and Moxifloxacin in Healthy Volunteers
114117 Completed A phase II, double blind, exploratory, parallel-group, placebocontrolled clinical study to assess two dosing regimens of GSK2402968 for efficacy, safety, tolerability and pharmacokinetics in ambulant subjects with Duchenne muscular dystrophy
114118 Completed A double-blind, escalating dose, randomized, placebo-controlled study to assess the pharmacokinetics, safety and tolerability of single subcutaneous injections of GSK2402968 in non-ambulant subjects with Duchenne muscular dystrophy
114125 Completed Drug Use Investigation for AVOLVE(BPH)
114128 Completed Drug Use Investigation for Arepanrix® (H1N1)
114130 Completed A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Sitagliptin in Subjects With Type 2 Diabetes Mellitus With Renal Impairment Study Listed on ClinicalStudyDataRequest.com
114136 Completed A single dose, open label, nonrandomized, study to evaluate the pharmacokinetics and absolute bioavailability of GSK962040 given as an oral dose simultaneously with an intravenous microtracer dose of [14C]-GSK962040 in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
114137 Completed An open label, randomized, up-titration study to assess the effect of urine sample handling procedures on the safety results of urine obtained from healthy subjects receiving repeat doses of ezogabine/retigabine. Study Listed on ClinicalStudyDataRequest.com
114151 Completed A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects with Moderately-to-Severely Active Crohn's Disease
114155 Completed An open-label pilot study to evaluate the safety, tolerability,pharmacokinetics, exploratory efficacy and pharmacodynamicsof oral pazopanib administered for 28 days to neovascular age-relatedmacular degeneration patients
114156 Completed A Long-term Study to Evaluate the Safety and Tolerability of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Japanese Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
114157 Terminated A 52 week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects with Crohn’s Disease
114161 Completed A Six-Month Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Denosumab in Indian Postmenopausal Women with Osteoporosis
114163 Completed A Six Month Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study with a Six Month Open-Label Extension to Evaluate the Efficacy and Safety of Denosumab in Korean Postmenopausal Women with Osteoporosis
114165 Completed A Twelve-Month Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Denosumab in Chinese Postmenopausal Women with Osteoporosis at Increased Risk of Fracture
114169 Completed A 24 Week Study to Evaluate the Predictive Ability of the COPD Assessment Test (CAT) for Acute Exacerbations (PACE) in Patients with Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
114174 Completed Impact of GSK Biologicals’ 2189242A vaccine on nasopharyngeal carriage, safety and immunogenicity when co-administered with routine EPI vaccines in infants following safety assessment in children aged 2-4 years in The Gambia Study Listed on ClinicalStudyDataRequest.com
114176 Terminated Post-marketing safety study to assess the risk of spontaneous abortion following administration of CERVARIX in the United States and Canada
114179 Completed A Randomized, Open-Label, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide in Subjects With Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
114182 Completed Safety and immunogenicity of GSK2186877A candidate seasonal influenza vaccine in healthy children 6 to 35 months of age. Study Listed on ClinicalStudyDataRequest.com
114187 Completed A randomized, single blind, placebo-controlled, three period crossover, dose selection study to evaluate the effect of GSK256073, an HM74A receptor agonist, on glucose and NEFA 24 hour profile in type 2 diabetic patients. Study Listed on ClinicalStudyDataRequest.com
114197 Completed A Randomized, Single-blind, Parallel-group, Placebo-controlled, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab Administered Subcutaneously to Healthy Adults in China
114203 Completed A Single Dose, Randomized, Five-Period Crossover Study to Assess the Relative Bioavailability of Four New Formulations of the CCR9 Receptor Antagonist GSK1605786A (CCX282) in Healthy Male and Female Subjects
114204 Completed A multicentre, randomized, laboratory-blinded, parallel-group study to demonstrate the efficacy and tolerability of ferrous bisglycinate chelate in iron deficiency anaemia and to compare these with those of ferrous ascorbate.
114219 Completed A multicenter, randomized, single blind, active controlled, parallel group study to determine efficacy and safety of nebulized fluticasone propionate 1mg BID compared with nebulized budesonide 2mg BID administered for 12 weeks in Chinese adult and adolescent patients with severe persistent asthma

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.